A gel placed after surgery slowed brain tumor growth in mice
Original title: Mitochondria-Targeted Lonidamine Hydrogels for Postsurgical Elimination of Glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in mice.
The short version
In mice, a gel left in place after surgery helped hold back brain tumor regrowth.
What was studied. Scientists made a gel that carries a cancer drug called lonidamine. They tested it in mice that had brain tumors taken out by surgery.
What they found. The drug was joined to a tiny piece of protein that enters the cell's power packs. This made it 19 times stronger than the drug on its own. In the mice, the gel slowed tumor growth and helped them live longer after surgery.
What this means, and what it doesn't
What it could mean: glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary often comes back after surgery. This is an early idea for treating the spot where the tumor was. It may help guide future work on gels that release drugs slowly.
What it doesn't mean: This does not mean a new treatment is here. The work was done only in mice, not in people. No one knows yet if it is safe or helpful for humans. It is not a cure, and it is far from everyday care.
Source: PubMed, August 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.